- Home
- LILA vs SPRY Comparison
LILA vs SPRY Comparison
Compare LILA & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LILA
- SPRY
- Stock Information
- Founded
- LILA 2017
- SPRY 2015
- Country
- LILA Bermuda
- SPRY United States
- Employees
- LILA N/A
- SPRY N/A
- Industry
- LILA Cable & Other Pay Television Services
- SPRY Biotechnology: Pharmaceutical Preparations
- Sector
- LILA Telecommunications
- SPRY Health Care
- Exchange
- LILA Nasdaq
- SPRY Nasdaq
- Market Cap
- LILA 1.1B
- SPRY 1.2B
- IPO Year
- LILA N/A
- SPRY N/A
- Fundamental
- Price
- LILA $4.56
- SPRY $13.61
- Analyst Decision
- LILA Buy
- SPRY Strong Buy
- Analyst Count
- LILA 2
- SPRY 4
- Target Price
- LILA $7.90
- SPRY $28.75
- AVG Volume (30 Days)
- LILA 613.6K
- SPRY 1.3M
- Earning Date
- LILA 05-07-2025
- SPRY 05-14-2025
- Dividend Yield
- LILA N/A
- SPRY N/A
- EPS Growth
- LILA N/A
- SPRY N/A
- EPS
- LILA N/A
- SPRY 0.08
- Revenue
- LILA $4,441,000,000.00
- SPRY $89,149,000.00
- Revenue This Year
- LILA $4.42
- SPRY $1.49
- Revenue Next Year
- LILA $3.59
- SPRY $141.68
- P/E Ratio
- LILA N/A
- SPRY $169.75
- Revenue Growth
- LILA N/A
- SPRY 297063.34
- 52 Week Low
- LILA $5.12
- SPRY $7.55
- 52 Week High
- LILA $10.82
- SPRY $18.51
- Technical
- Relative Strength Index (RSI)
- LILA 33.46
- SPRY 50.15
- Support Level
- LILA $4.26
- SPRY $13.06
- Resistance Level
- LILA $5.60
- SPRY $15.06
- Average True Range (ATR)
- LILA 0.24
- SPRY 0.66
- MACD
- LILA -0.01
- SPRY -0.16
- Stochastic Oscillator
- LILA 40.29
- SPRY 29.41
About LILA Liberty Latin America Ltd.
Liberty Latin America Ltd is a telecommunications company. It is a provider of video, broadband internet, fixed-line telephony, and mobile services to residential and business customers. The company's reportable segments include C&W Caribbean, Liberty Networks, C&W Panama, VTR, Liberty Puerto Rico and Liberty Costa Rica. The company generates the majority of its revenue from C&W Caribbean, and Liberty Puerto Rico segments.
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.